Drug Interactions between Viekira Pak and Viekira XR
This report displays the potential drug interactions for the following 2 drugs:
- Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir)
- Viekira XR (dasabuvir/ombitasvir/paritaprevir/ritonavir)
Interactions between your drugs
No interactions were found between Viekira Pak and Viekira XR. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Viekira Pak
A total of 696 drugs are known to interact with Viekira Pak.
- Viekira pak is in the drug class antiviral combinations.
- Viekira pak is used to treat Hepatitis C.
Viekira XR
A total of 696 drugs are known to interact with Viekira XR.
- Viekira xr is in the drug class antiviral combinations.
- Viekira xr is used to treat Hepatitis C.
Drug and food interactions
ritonavir food
Applies to: Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir) and Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
Ritonavir should be taken with food to lessen gastrointestinal side effects. It is important that you take this medication exactly as prescribed by your doctor. Do not change your treatment or stop treatment without first talking to your doctor.
paritaprevir food
Applies to: Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir) and Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
Food significantly increases the absorption of paritaprevir. You should take each dose of paritaprevir with a meal. Taking it on an empty stomach may lead to inadequate blood levels and reduced effectiveness of the medication.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Protease inhibitors
Therapeutic duplication
The recommended maximum number of medicines in the 'protease inhibitors' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'protease inhibitors' category:
- Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir)
- Viekira XR (dasabuvir/ombitasvir/paritaprevir/ritonavir)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
Antiviral boosters
Therapeutic duplication
The recommended maximum number of medicines in the 'antiviral boosters' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'antiviral boosters' category:
- Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir)
- Viekira XR (dasabuvir/ombitasvir/paritaprevir/ritonavir)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
Ns5a inhibitors
Therapeutic duplication
The recommended maximum number of medicines in the 'NS5A inhibitors' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'NS5A inhibitors' category:
- Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir)
- Viekira XR (dasabuvir/ombitasvir/paritaprevir/ritonavir)
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.